Successful Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide in a Severe Combined Immune Deficiency Patient: a First Report
- 5 May 2016
- journal article
- letter
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 36 (5) , 437-440
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in a Patient with Chronic Granulomatous Disease and Active Infection: A First ReportJournal of Clinical Immunology, 2015
- Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling GraftsTransplantation and Cellular Therapy, 2014
- Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009New England Journal of Medicine, 2014
- T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donorBone Marrow Transplantation, 2014
- How I treat severe combined immunodeficiencyBlood, 2013
- B-cell reconstitution for SCID: Should a conditioning regimen be used in SCID treatment?Journal of Allergy and Clinical Immunology, 2013
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2012
- Haematopoietic stem cell transplantation for SCID patients: where do we stand?British Journal of Haematology, 2012
- Neonatal diagnosis of severe combined immunodeficiency leads to significantly improved survival outcome: the case for newborn screeningBlood, 2011